Growth Metrics

Pulmonx (LUNG) Depreciation & Amortization (CF) (2019 - 2025)

Pulmonx (LUNG) has disclosed Depreciation & Amortization (CF) for 7 consecutive years, with $246000.0 as the latest value for Q3 2025.

  • Quarterly Depreciation & Amortization (CF) fell 34.57% to $246000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Sep 2025, down 24.83% year-over-year, with the annual reading at $1.5 million for FY2024, 3.55% down from the prior year.
  • Depreciation & Amortization (CF) for Q3 2025 was $246000.0 at Pulmonx, down from $299000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $437000.0 in Q1 2023, with the low at $141000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $328631.6, with a median of $374000.0 recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (CF) surged 192.19% in 2021, then plummeted 34.57% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $374000.0 in 2021, then grew by 3.21% to $386000.0 in 2022, then fell by 25.65% to $287000.0 in 2023, then rose by 2.44% to $294000.0 in 2024, then fell by 16.33% to $246000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $246000.0, $299000.0, and $278000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.